Institute of Metabolism and Systems Research (IMSR) Changing lives and advancing knowledge through innovative metabolism, maternal health and hormone research
News Lifesaving solution dramatically reduces severe bleeding after childbirth A trial of a set of interventions to manage postpartum haemorrhage, published in the New England Journal of Medicine, found a 60% reduction in heavy bleeding
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
13 July 2021 Partnership will create the next generation of researchers to transform global healthcare The Universities of Birmingham, Leicester and Nottingham have launched a partnership training the next generation of leading researchers the skills required to transform our understanding and treatment of disease.
21 June 2021 Research shows increased risk of chronic kidney disease in people with 'healthy' obesity People with 'healthy' obesity have a 66% increased risk of chronic kidney disease, finds a new study led by the University of Birmingham.
15 June 2021 Birmingham experts join drive to address global burden of maternal sepsis University of Birmingham health experts are working in a research partnership in East Africa aiming to reduce the number of mothers dying from maternal sepsis.
15 June 2021 Northern News Wire: Birmingham Experts Join Drive to Address Global Burden of Maternal Sepsis in Uganda and Malawi. Professor Arri Coomarasamy is quoted in Northern News Wire (Uganda) on joining the drive to address the global burden of maternal sepsis in Uganda and Malawi.
07 May 2021 Trial seeks to revolutionise diagnosis and treatment of life-threatening post-partum haemorrhage Post-partum haemorrhage (PPH) accounts for 27% of all maternal deaths worldwide. PPH disproportionately affects mothers from low- and middle-income countries.
06 May 2021 University of Birmingham joins drug discovery collaboration with Evotec and Bristol Myers Squibb The University of Birmingham is part of a new industry collaboration to accelerate drug discovery projects that will fast track research from lab to patient.